According to Monte Rosa Therapeutics's latest financial reports the company's current earnings are โฌ0.18 Billion. In 2024 the company made an earning of -โฌ59.72 Million, an increase over its 2023 earnings that were of -โฌ0.12 Billion. The earnings displayed on this page is the company's Pretax Income.